Nanoencapsulation as a Way to Control the Release and to Increase the Photostability of Clobetasol Propionate: Influence of the Nanostructured System

被引:77
作者
Fontana, M. C. [1 ]
Coradini, K. [2 ]
Guterres, S. S. [3 ]
Pohlmann, A. R. [4 ]
Beck, R. C. R. [1 ]
机构
[1] Univ Fed Santa Maria, Dept Farm Ind, Programa Posgrad Ciencias Farmaceut, BR-91705900 Santa Maria, RS, Brazil
[2] Univ Fed Santa Maria, Fac Farm, BR-91705900 Santa Maria, RS, Brazil
[3] Univ Fed Rio Grande do Sul, Fac Farm, BR-90610000 Porto Alegre, RS, Brazil
[4] Univ Fed Rio Grande do Sul, Dept Quim Organ, Inst Quim, BR-91501970 Porto Alegre, RS, Brazil
关键词
Clobetasol Propionate; Nanocapsules; Nanoemulsions; Nanoparticles; In Vitro Drug Release; Photostability; SOLID LIPID NANOPARTICLES; SOLVENT DIFFUSION METHOD; PHYSICOCHEMICAL CHARACTERIZATION; TOPICAL GLUCOCORTICOIDS; OCTYL METHOXYCINNAMATE; LOADED NANOCAPSULES; AQUEOUS SYSTEM; POLYMERIC WALL; DRUG CARRIERS; NANOEMULSIONS;
D O I
10.1166/jbn.2009.1030
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
The aim of this study was to prepare and to evaluate the physicochemical and in vitro drug release characteristics of different nanostructured systems containing clobetasol propionate (CP): CP-loaded polymeric nanoparticles (nanocapsules and nanospheres) and CP-loaded nanoemulsion. Physicochemical characteristics of the formulations were monitored up to 9 months after preparation by means of drug content, encapsulation efficiency, mean size, polydispersity index, pH, and zeta potential. In vitro drug release studies were carried out using the dialysis bag method. Photostability of CP-loaded nanoparticles was evaluated by their exposition to UVA radiation. All formulations presented nanometric mean size (140-220 nm), polydispersity index below 0.25, neutral pH values, negative zeta potential and encapsulation efficiency close to 100%. All these parameters, except pH, remained unchangeable up to 9 months of storage at room temperature for CP-loaded nanocapsules. On the other hand, CP-loaded nanospheres and nanoemulsion showed an increase in their mean size, as well as in polydispersity index under storage (after 3 and 6 months, respectively). In vitro drug release studies showed a controlled release of CP from nanoparticles (nanocapsules > nanospheres > nanoemulsion) with a low burst release. Photostability of CP under UVA radiation was improved by its incorporation into nanoparticles (nanocapsules > nanoemulsions > nanospheres).
引用
收藏
页码:254 / 263
页数:10
相关论文
共 45 条
[1]  
Almeida JS, 2009, LAT AM J PHARM, V28, P165
[2]   Human skin penetration and distribution of nimesulide from hydrophilic gels containing nanocarriers [J].
Alves, Marta P. ;
Scarrone, Ana L. ;
Santos, Marcos ;
Pohlmann, Adriana R. ;
Guterres, Silvia S. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2007, 341 (1-2) :215-220
[3]  
[Anonymous], 2005, INT C HARM ICH VAL A
[4]  
Beck Ruy C. R., 2003, Acta Farmaceutica Bonaerense, V22, P11
[5]  
*BRIT MED ASS ROYA, 2004, BRIT NAT FORM
[6]   Comparative in vitro evaluation of several colloidal systems, nanoparticles, nanocapsules, and nanoemulsions, as ocular drug carriers [J].
Calvo, P ;
VilaJato, JL ;
Alonso, MJ .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 85 (05) :530-536
[7]   A new delivery system of clobetasol-17-propionate (lipid-loaded microspheres 0•025%) compared with a conventional formulation (lipophilic ointment in a hydrophilic phase 0.025%) in topical treatment of atrophic/erosive oral lichen planus.: A Phase IV, randomized, observer-blinded, parallel group clinical trial [J].
Campisi, G ;
Giandalia, G ;
De Caro, V ;
Di Liberto, C ;
Aricò, P ;
Giannola, LI .
BRITISH JOURNAL OF DERMATOLOGY, 2004, 150 (05) :984-990
[8]  
CAPO JIT, 2004, REV CUBANA FARM, V38, P2
[9]   Diffusion and mathematical modeling of release profiles from nanocarriers [J].
Cruz, L ;
Soares, LU ;
Dalla Costa, T ;
Mezzalira, G ;
da Silveira, NP ;
Guterres, SS ;
Pohlmann, AR .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 313 (1-2) :198-205
[10]   Primidone-loaded poly-ε-caprolactone nanocapsules:: incorporation efficiency and in vitro release profiles [J].
Ferranti, V ;
Marchais, H ;
Chabenat, C ;
Orecchioni, AM ;
Lafont, O .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 193 (01) :107-111